Barclays has announced the appointment of Kieran Whitty as the new Co-Head of Healthcare for its operations across Europe, the Middle East, and Africa (EMEA), effective this June. Whitty will work alongside Sid Chhibbar, who has held the role since 2015. This strategic move highlights Barclays’ commitment to strengthening its position in the UK and Continental Europe’s healthcare market, a critical area for its Investment Banking division.
Whitty joins Barclays with an impressive 18-year track record at Bank of America, where he served as a Managing Director in the EMEA Healthcare team. His extensive experience includes advising various clients across the healthcare sector, particularly in healthcare services and medical technologies. Noteworthy is his recent advisory role to PureHealth on its acquisition of Hellenic Healthcare Group and assisting Nordic Capital with its exit from Sunrise Medical.
Richard Landgarten, the Global Head of Healthcare and Real Estate at Barclays, mentioned, “Kieran’s extensive industry expertise and his proven track record in helping clients will be hugely complementary to our already strong healthcare practice.” This sentiment echoes the firm’s dedication to enhancing its capabilities to better support the expanding needs of its clients.
Landgarten further emphasized the importance of Whitty’s role, stating, “We are delighted to be able to provide clients with expanded capabilities to support their growth.” In line with this thought, Alisdair Gayne, Co-Head of Investment Banking in EMEA, remarked, “Kieran’s appointment demonstrates our continued investment in senior talent and our commitment to helping clients.”
This latest addition to the team is part of a broader strategy to deepen relationships with clients while driving growth and delivering returns for shareholders. Barclays continues to invest in its EMEA framework, indicating its focus on providing robust support and expertise in a rapidly changing industry landscape.
As Whitty prepares to transition into his new role based in London, he will be reporting directly to Landgarten. His arrival is anticipated to bolster Barclays’ existing healthcare practice and contribute to its continuous growth in the sector.
The appointment not only ends Whitty’s significant tenure at Bank of America, where he has gained a wealth of knowledge and insights, but also signals his readiness to tackle fresh challenges within a new firm. Barclays is confident that Whitty’s addition to their leadership team will enhance their offerings, especially amid a competitive landscape in the healthcare sector.
In summary, Kieran Whitty’s appointment as Co-Head of Healthcare EMEA underlines Barclays’ ongoing commitment to the healthcare industry while reinforcing its strategic focus on growth and client support. As the healthcare market evolves, the company aims to position itself at the forefront of advisory services, ensuring it meets the needs of its diverse clientele.
